N-Allyl-1-indanamine is related to Rasagiline (R126030) which has been used to increase the availability of dopamine at striatal receptors as a method to treat Parkinson’s disease.
參考文獻
Mi, K., et al.: J. Sep. Sci., 36, 3682-3687 (2013); Youdim, M.B.H., et al.: Br. J. Pharmacol., 132, 500 (2001); Finberg, J.P., Rambam Maimonides Med. J., 1 (2010)